Stereotaxis Completes Acquisition of Robocath

Stereotaxis has completed its previously announced acquisition of Robocath, a French innovator in robotic technologies for interventional cardiology and neurointerventions. The deal integrates Robocath’s bionic robotic solutions, including the R-One system which holds CE and NMPA certifications, into Stereotaxis’s existing endovascular robotics platform.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.